Corona Remedies is a finished-dose manufacturer based in India. It appears in 53 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with UZPHARM (UZ), ZAMRA (ZM) and NAFDAC (NG). Its GMP standing is certified by EMA, CDSCO (India) and UZPHARM (UZ), among 4 authorities. Customs aggregates show $5.5M of exports covering 413 molecules to 18 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Ahmedabad, India | Not on file |
| bhaylaahmeda bad 382 220, India | Not on file |
| HIMACHAL PRADESH INDIA, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| UZPHARM (UZ) | 42 | 2 |
| ZAMRA (ZM) | 3 | None |
| NAFDAC (NG) | 3 | 1 |
| MINSA (CR) | 2 | None |
| EEC_EAEU | 2 | None |
| CDSCO (India) | 1 | 2 |
| EMA | None | 4 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.2M | 10 |
| 2025 | Not reported | $5.5M | 18 |
| 2024 | Not reported | $5.0M | 20 |
| 2023 | Not reported | $4.7M | 17 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Corona Remedies comes back tiered against every other supplier able to file there.
Start for free